Econochlor Related Published Studies
Well-designed clinical trials related to Econochlor (Chloramphenicol Ophthalmic)
Gatifloxacin versus chloramphenicol for uncomplicated enteric fever: an open-label, randomised, controlled trial. [2011.06]
Does single application of topical chloramphenicol to high risk sutured wounds reduce incidence of wound infection after minor surgery? Prospective randomised placebo controlled double blind trial. [2009.01.15]
Chloramphenicol versus ampicillin plus gentamicin for community acquired very severe pneumonia among children aged 2-59 months in low resource settings: multicentre randomised controlled trial (SPEAR study). [2008.01.12]
Randomised equivalency trial comparing 2.5% povidone-iodine eye drops and ophthalmic chloramphenicol for preventing neonatal conjunctivitis in a trachoma endemic area in southern Mexico. [2007.11]
Open-label randomized trial of oral trimethoprim-sulfamethoxazole, doxycycline, and chloramphenicol compared with trimethoprim-sulfamethoxazole and doxycycline for maintenance therapy of melioidosis. [2005.10]
Ceftriaxone as effective as long-acting chloramphenicol in short-course treatment of meningococcal meningitis during epidemics: a randomised non-inferiority study. [2005.07.23]
Chloramphenicol treatment for acute infective conjunctivitis in children in primary care: a randomised double-blind placebo-controlled trial. [2005.07.02]
A randomized comparison of oral chloramphenicol versus ofloxacin in the treatment of uncomplicated typhoid fever in Laos. [2005.06]
Well-designed clinical trials possibly related to Econochlor (Chloramphenicol Ophthalmic)
New insights into meticillin-resistant Staphylococcus aureus (MRSA) pathogenesis,
treatment and resistance. [2012]
Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever). [2011.10.05]
Antibiotics in severely malnourished children: systematic review of efficacy, safety and pharmacokinetics. [2011.08.01]
Pharmacokinetics of a florfenicol-tylosin combination after intravenous and intramuscular administration to beagle dogs. [2011.04]
Effects of dietary antibiotic growth promoter and Saccharomyces cerevisiae fermentation product on production, intestinal bacterial community, and nonspecific immunity of hybrid tilapia (Oreochromis niloticus female x Oreochromis aureus male). [2011.01]
In vivo assessment of the effect of an adhesive for complete dentures on colonisation of Candida species. [2010.12]
Antibiotic use in obstetric fistula repair: single blinded randomized clinical trial. [2010.07]
Efficacy of florfenicol for control of mortality caused by Flavobacterium columnare infection in channel catfish. [2010.06]
Nasopharyngeal carriage of S. pneumoniae among young children in rural Nepal. [2009.09]
Aerosol antibiotic therapy in children with chronic upper airway infections: a potential alternative to surgery. [2009.04]
The outcome of non-typhoidal salmonella meningitis in Malawian children, 1997-2006. [2009.03]
Azithromycin for treating uncomplicated typhoid and paratyphoid fever (enteric fever). [2008.10.08]
Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever). [2008.10.08]
Inhaled thiamphenicol and acetylcysteine in children with acute bacterial rhinopharyngitis. [2008.07]
Dental amalgam and antibiotic- and/or mercury-resistant bacteria. [2008.05]
Pharmacokinetics of florfenicol and its metabolite, florfenicol amine, in dogs. [2008.02]
Influence of povidone-iodine preoperative showers on skin colonization in elective plastic surgery procedures. [2008.01]
A therapeutic approach in the treatment of infections of the upper airways: thiamphenicol glycinate acetylcysteinate in sequential treatment (systemic-inhalatory route). [2007.07]
An evaluation of the relative efficacy of tulathromycin for the treatment of undifferentiated fever in feedlot calves in Nebraska. [2007.06]
Effects of Saccharomyces cerevisiae subspecies boulardii CNCM I-1079 on feed intake by healthy beef cattle treated with florfenicol and on health and performance of newly received beef heifers. [2007.05]
Efficacy of enrofloxacin, florfenicol and amoxicillin against Ornithobacterium rhinotracheale and Escherichia coli O2:K1 dual infection in turkeys following APV priming. [2007.03.31]
Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever. [2007.03]
[Nasal carriage of Streptococcus pneumoniae in elderly subjects according to vaccination status.] [2007.02]
Pharmacokinetics of florfenicol and its major metabolite, florfenicol amine, in rabbits. [2007.02]
Residue depletion of florfenicol and its metabolite florfenicol amine in Swine tissues after intramuscular administration. [2006.12.13]
Corneal ulceration in south-east Asia III: prevention of fungal keratitis at the village level in south India using topical antibiotics. [2006.12]
A randomised controlled trial of management strategies for acute infective conjunctivitis in general practice. [2006.08.12]
Comparison of the efficacy of four antimicrobial treatment schemes against experimental Ornithobacterium rhinotracheale infection in turkey poults pre-infected with avian pneumovirus. [2006.06]
Post-operative sequelae of lower third molar removal: a literature review and pilot study on the effect of Covomycin D. [2006.05]
Assessing the effect of a single dose florfenicol treatment in feedlot cattle on the antimicrobial resistance patterns in faecal Escherichia coli. [2005.09]
Enzymatic versus autolytic debridement of chronic leg ulcers: a prospective randomised trial. [2005.07]
Evaluation of the therapeutic activity of tulathromycin against swine respiratory disease on farms in Europe. [2005.06]
Comparative efficacy of tulathromycin versus florfenicol and tilmicosin against undifferentiated bovine respiratory disease in feedlot cattle. [2005.06]
Comparative efficacy of tulathromycin, tilmicosin, and florfenicol in the treatment of bovine respiratory disease in stocker cattle. [2005.06]
Efficacy of tulathromycin compared with tilmicosin and florfenicol for the control of respiratory disease in cattle at high risk of developing bovine respiratory disease. [2005.06]
Efficacy of tulathromycin in the treatment and prevention of natural outbreaks of bovine respiratory disease in European cattle. [2005.06]
Role of topical antibiotics in hip surgery. A prospective randomised study. [2005.06]
[Changes in bacterial flora of conjunctival sac in patients prophylacticaly treated with antibiotic before cataract operation] [2005]
Other research related to Econochlor (Chloramphenicol Ophthalmic)
Towards evidence-based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 3: Fucidic acid or chloramphenicol for neonates with sticky eyes. [2011.07]
Development and optimization of solid lipid nanoparticle formulation for ophthalmic delivery of chloramphenicol using a Box-Behnken design. [2011]
Gatifloxacin versus chloramphenicol for uncomplicated enteric fever: an
open-label, randomised, controlled trial. [2011]
Successful treatment of vancomycin-resistant Enterococcus faecium ventriculitis with combined intravenous and intraventricular chloramphenicol in a newborn. [2010.11]
Prescribing and sale of ophthalmic chloramphenicol following reclassification to over-the-counter availability. [2010.10]
Role of oxidative stress in reproductive toxicity induced by co-administration of chloramphenicol and multivitamin-haematinics complex in rats. [2010.09]
Is chloramphenicol making a comeback? [2010.06]
Changing antibiotic sensitivity pattern and scope of chloramphenicol in the management of hospitalised patients of typhoid fever. [2009.12]
Suppressing glioblastoma stem cell function by aldehyde dehydrogenase inhibition with chloramphenicol or disulfiram as a new treatment adjunct: an hypothesis. [2009.12]
Development and physical characterization of chloramphenicol loaded biodegradable nanoparticles for prolonged release. [2009.07]
Toxic effect and adaptation in Scenedesmus intermedius to anthropogenic chloramphenicol contamination: genetic versus physiological mechanisms to rapid acquisition of xenobiotic resistance. [2009.07]
A structural study of the interaction between the Dr haemagglutinin DraE and derivatives of chloramphenicol. [2009.06]
Depletion of chloramphenicol in trout after a hypothetic therapeutic treatment. [2009.04.01]
The bacterial Tn9 chloramphenicol resistance gene: an attractive DNA segment for Mos1 mariner insertions. [2008.12.27]
Inhibition of voriconazole metabolism by chloramphenicol in an adolescent with central nervous system aspergillosis. [2008.11]
Monitoring of Leuconostoc mesenteroides DRC starter in fermented vegetable by random integration of chloramphenicol acetyltransferase gene. [2008.09]
Liposomal phospholipid preparations of chloramphenicol for ophthalmic applications. [2008.07]
Monitoring of Leuconostoc mesenteroides DRC starter in fermented vegetable by random integration of chloramphenicol acetyltransferase gene. [2008.05.24]
Chloramphenicol-incorporated poly lactide-co-glycolide (PLGA) nanoparticles: formulation, characterization, technetium-99m labeling and biodistribution studies. [2008.05]
Anterior uveitis, poliosis, and skin hypopigmentation associated with topical chloramphenicol allergy following ptosis surgery. [2007.07]
Pharmacokinetics of florfenicol, thiamphenicol, and chloramphenicol in turkeys. [2007.04]
Chloramphenicol: screening and review to evaluate its potential beneficial effects in leukaemia. [2007.04]
A competitive enzyme-linked immunosorbent assay for determination of chloramphenicol. [2007.02]
Chloramphenicol pharmacokinetics in African children with severe malaria. [2006.08]
Characterization of the myelotoxicity of chloramphenicol succinate in the B6C3F1 mouse. [2006.04]
Does long-term chloramphenicol cause anaemia in Malawi? [2006.04]
Management of anemic effects of chloramphenicol using amino acids on albino rats infected with Salmonella typhi. [2006.03]
Cyclosporine-responsive thrombocytopenia in a patient with chloramphenicol-associated myelodysplastic syndrome. [2006.03]
Synergism of Leu-Lys rich antimicrobial peptides and chloramphenicol against bacterial cells. [2006.01]
[Inter-laboratory validation studies of biological method for determination of streptomycin in royal jelly] [2005.12]
Cultured skin loaded with tetracycline HCl and chloramphenicol as dermal delivery system: mathematical evaluation of the cultured skin containing antibiotics. [2005.11.28]
Linezolid-induced dyserythropoiesis: chloramphenicol toxicity revisited. [2005.10]
Effects of light and chloramphenicol stress on incorporation of nitrogen into cyanophycin in Synechocystis sp. strain PCC 6308. [2005.09.15]
Phase behavior of the microemulsions and the stability of the chloramphenicol in the microemulsion-based ocular drug delivery system. [2005.09.14]
Other possibly related research studies
A Versatile photocleavable bifunctional linker for facile synthesis of substrate-DNA conjugates for the selection of nucleic acid catalysts. [2007.01]
Scientific challenges in postmarketing surveillance of ocular adverse drug reactions. [2007.01]
Cloning and characterization of promoter-active DNA sequences from Streptococcus equisimilis. [2007.01]
Treating experimentally induced vibriosis (Listonella anguillarum) in cod, Gadus morhua L., with florfenicol. [2006.12]
A randomised controlled comparison of ofloxacin, azithromycin and an ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid resistant typhoid fever. [2006.12.04]
Antibiotic drug interactions. [2006.11]
Invasive pneumococcal disease in children<5 years of age in rural Mozambique. [2006.09]
Detergent capsules causing ocular injuries in children. [2006.07]
[Resistance to antimicrobial drugs in Enterococcus sp. strains isolated in hospitals of Northern Chile] [2006.09]
Serotype and antimicrobial susceptibility patterns of isolates of Streptococcus pneumoniae causing invasive disease in The Gambia 1996-2003. [2006.07]
Ocular methicillin-resistant Staphylococcus aureus infections in a newborn intensive care cohort. [2006.07]
Inhibition of protein and RNA synthesis in Escherichia coli results in declustering of plasmid RK2. [2006.09]
Antimicrobial susceptibility of invasive Streptococcus pneumoniae isolates in Portugal over an 11-year period. [2006.06]
Corneal ulceration in South East Asia. II: a strategy for the prevention of fungal keratitis at the village level in Burma. [2006.08]
Treatment of enteric fever in children on the basis of current trends of antimicrobial susceptibility of Salmonella enterica serovar typhi and paratyphi A. [2006.04]
Cutaneous myospherulosis and membranous lipodystrophy: extensive presentation in a patient with severe steroid-induced dermal atrophy. [2006.04]
[Molecular mechanism of multiple-drug and pan-drug resistance among Acinetobacter species] [2006.01.03]
Old dogs that learn new tricks: modified antimicrobial agents that escape pre-existing resistance mechanisms. [2006.06]
[Rickettsialpox: report of two cases imported from South Africa] [2005.12]
Corneal ulceration in South East Asia. I: a model for the prevention of bacterial ulcers at the village level in rural Bhutan. [2006.03]
Biosynthetic requirements for the repair of sublethal membrane damage in Escherichia coli cells after pulsed electric fields. [2006.03]
|
